| Customization: | Available |
|---|---|
| Package: | 10AMP/Box |
| Composition: | Octreotide Acetate |
|
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product | Dose | Package |
| Octreotide Acetate Injection | 100mcg/1ml | 10Amp/box |
Octreotide Acetate Injection is a medication used to treat various hormone-related conditions, including acromegaly, carcinoid tumors, vasoactive intestinal peptide-secreting tumors (VIPomas), and gastrointestinal bleeding. It is a synthetic analogue of somatostatin, a hormone that inhibits the release of several other hormones in the body. Octreotide acetate injection works by binding to somatostatin receptors, thereby reducing the secretion of hormones such as growth hormone, insulin, glucagon, and serotonin, which are involved in the pathophysiology of these conditions.
Acromegaly: Octreotide acetate injection is used for the long-term treatment of acromegaly, a condition characterized by excessive growth hormone production, typically caused by a pituitary adenoma.
Carcinoid Tumors: Octreotide acetate injection is indicated for the treatment of symptoms associated with carcinoid tumors, including flushing, diarrhea, abdominal pain, and carcinoid syndrome.
VIPomas: Octreotide acetate injection is used to control symptoms associated with VIPomas, including watery diarrhea, electrolyte imbalances, and hypokalemia.
Octreotide acetate injection is generally well-tolerated, but it may cause side effects such as injection site reactions, gastrointestinal disturbances (including diarrhea, abdominal pain, and nausea), gallbladder problems, and changes in glucose metabolism.
Patients with a history of gallbladder disease, diabetes mellitus, or impaired glucose tolerance may require monitoring of gallbladder function and glucose levels during treatment with octreotide acetate injection.
Administration:
Octreotide acetate injection is administered subcutaneously (under the skin) or intramuscularly (into the muscle) by a healthcare professional. The dosage and frequency of administration depend on the specific indication being treated, the severity of symptoms, and individual patient response.
For long-term treatment of conditions such as acromegaly or carcinoid tumors, octreotide acetate injection may be administered on a regular schedule, typically ranging from once daily to multiple times per day.
){kind=link}